MIRONID
Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
MIRONID
Industry:
Ad Network Biotechnology Health Diagnostics Therapeutics
Founded:
2014-01-01
Address:
Newhouse, North Lanarkshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.mironid.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
6.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt WordPress Font Awesome Apache Wordpress Plugins
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Epidarex Capital
Epidarex Capital investment in Series A - Mironid
Scottish Investment Bank
Scottish Investment Bank investment in Series A - Mironid
Official Site Inspections
http://www.mironid.com
- Host name: 185-151-30-161.ptr4.stackcp.net
- IP address: 185.151.30.161
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Mironid"
Mironid
Oct 30, 2024 · At the heart of Mironid ® ’s innovation is our mission to transform the treatment landscape for patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) and …See details»
About us - Mironid
Mironid® is currently building and progressing a pipeline of drug development programmes that are targeted at cAMP degrading phosphodiesterase enzymes. The goal is to generate novel …See details»
Mironid - Crunchbase Company Profile & Funding
Mironid is a drug discovery company focused on therapeutics for degenerative kidney diseases, chronic inflammatory diseases, and cancer. Mironid may be growing as evidenced by the extension of its Series A funding round, with a …See details»
Mironid® Limited - LinkedIn
Mironid Limited is an innovative new drug discovery company that develops proprietary drug candidate molecules by modulating the activity of key cell signalling proteins. This allows us to...See details»
Mironid Company Profile 2024: Valuation, Funding & Investors
Developer of a therapeutic device designed to offer treatment for kidney diseases, chronic inflammatory diseases, and cancer.See details»
Our people - Mironid
Mironid ® is a vibrant, growing, patient focused company led by an experienced team, which has an impressive track record of delivering innovative therapeutics for unmet clinical needs.See details»
Mironid - Overview, News & Similar companies | ZoomInfo.com
May 28, 2024 · Mironid contact info: Phone number: +44 1698539607 Website: www.mironid.com What does Mironid do? Mironid® Limited, based in Scotland, UK, is an innovative drug …See details»
New drug compound could tackle major life-limiting …
Jun 21, 2019 · Working with Glasgow-based biotech company Mironid and colleagues in the US, the Sheffield researchers have tested a compound developed by Mironid in the lab to treat ADPKD, an hereditary disease which …See details»
Neil Wilkie - CEO at Mironid - The Org
A scientific business leader with over twenty years experience of in the pharmaceutical, biotech, and life sciences investment markets.See details»
Mironid - VentureRadar
Our mission is to become a world leader in cell signalling directed therapeutic development. Mironid® is currently building and progressing a pipeline of early stage drug discovery …See details»
Mironid extends Series A round raising £35 million to date for ...
September 13, 2023: Glasgow, Scotland – Mironid, a biopharmaceutical company developing small molecule therapeutics for the treatment of Autosomal Dominant Polycystic Kidney …See details»
Mironid Company Profile - Office Locations, Competitors ... - Craft
Mironid is a drug discovery company. It develops drug candidate molecules by modulating the activity of key cell-signaling proteins. Mironid's pipeline is aimed at developing treatments for …See details»
Mironid extends Series A round raising £35 million to date for ...
September 13, 2023: Glasgow, Scotland – Mironid, a biopharmaceutical company developing small molecule therapeutics for the treatment of Autosomal Dominant Polycystic Kidney …See details»
Mironid Presents Translational Data in Oral Presentation at the ...
28 May 2024, Glasgow, Scotland – Mironid, a biopharmaceutical company developing small molecule therapeutics for the treatment of Autosomal Dominant Polycystic Kidney Disease …See details»
Mironid - Biotech Careers
Mironid is a Glasgow-based biotech developing small molecule therapeutics for the treatment of autosomal dominant polycystic kidney disease, a life-threatening hereditary condition. …See details»
Mironid attending BIO-Europe 2024 – Mironid
Oct 30, 2024 · Our Chief Executive Officer Neil Wilkie will be in Stockholm from 4-6 November attending the 30th annual BIO-Europe conference. At Mironid, we are committed to …See details»
Mironid advances finances for small molecule development
Sep 18, 2023 · Mironid has raised $43.3 million to date for development of first-in-class small molecules to treat life-threatening hereditary kidney disease.See details»
Mironid reaches $43.7M to date in Series A extension to fund …
Sep 13, 2023 · Mironid has raised a total of £35 million ($43.7 million) since its inception with the help of a Series A extension raise, setting it up to get its lead kidney ...See details»
Mironid | VentureRadar
Similar Companies: Nimbus Therapeutics USA Privately Held Nimbus Therapeutics harnesses cutting-edge technologies to design exquisitely selective small molecule therapeutics. Our …See details»
Mironid Ltd. (Mironid Ltd.) - 药物管线_专利_临床试验_投融营收_最 …
Mironid, a biopharmaceutical company developing small molecule therapeutics for the treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD), a life-threatening hereditary …See details»